MAP2K2 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-MAP2K2 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMAP2K2
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size0.05 mL, 0.1 mL, 0.2 mL
Concentration1mg/ml
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionMEK1 and MAP2K2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (1-3). Activation of MEK1 and MAP2K2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx (1-4). Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells (4). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites
ImmunogenImmunogen: C term -peptide of human MAP2K2 Calculated Molecular Weight: 44kDa
Other Names[MEK2: MAP2K2; FLJ26075; MAPKK2; MEK2; MKK2; PRKMK2], [MAP2K2; MAP2K2; CFC4; MEK2; MKK2; MAPKK2; PRKMK2; MEK2; MKK2; PRKMK2; MAP kinase kinase 2; MAPKK 2; MEK 2]
Gene, Accession #[MAP2K2], Gene ID: 5605, NCBI: P36507.1, UniProt: P36507
Catalog #MBS125114
Price$200, $275, $430
Order / More InfoMAP2K2 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.